What is the main business of Sativa Wellness Poland?

The main business activity of Sativa Wellness Poland focuses on manufacture of basic pharmaceutical products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 28, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Bukowa 2, 26-026 Bilcza.

What is the share capital?

The share capital of the company is PLN 457,600 (approx. $123,609).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company generated total revenue of USD 185,251, representing an increase of 151.1% compared to 2024.

No, the company recorded a net loss of USD 1,103,922 in 2025. For comparison, in 2024 the loss was USD 509,009, meaning the company increased its loss by 116.4%.

What is the largest operating cost?

The largest operating cost category falls under depreciation and amortization. This category amounted to USD 412,216 in 2025, representing 71% of all operating expenses.

Sativa Wellness Polandsp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-05-28

Share capital

457,600.00 PLN

Registered address

ul. Bukowa 2, 26-026 Bilcza, Poland

Electronic delivery address

AE:PL-70044-72579-JAGWE-21

Financials

Revenue history (in k)

Filing timeliness

4 of 5 financial statements were filed late (the longest delay 455 days for 2023).

202527/10/2026
202413/10/2025
202313/10/2025
202213/07/2023
202113/10/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 185.25kMedianUSD 164.14kAverageUSD 2.27m

Net profit

This companyUSD -1.10mMedianUSD 1.03kAverageUSD 108.21k

Operating costs

This companyUSD 579.12kMedianUSD 187.05kAverageUSD 2.07m

Assets

This companyUSD 1.13mMedianUSD 115.76kAverageUSD 1.52m

Industry

Authorized Representatives

Krystyna Bojek – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations and sign on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Krystyna Bojekage 68	8,236	$111,237.17	89.9913%
Waldemar Bojekage 68	916	$12,371.69	10.0087%

Krystyna Bojek and Waldemar Bojek hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-06-09.

Bank Pekao SA
25 1240 6292 1789 0011 2250 1853
Bank Pekao SA
36 1240 6292 1978 0011 2250 1808
Bank Pekao SA
95 1240 4416 1111 0011 0698 7439

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$5,129$5,129
Buildings and premises	$713.3K$713,339

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Biocanto Pharmasp. z o.o.	$186,097.96	biocanto.pl
Nature's Voicesp. z o.o.	$181,977.76	naturesvoice.eu
Vilowaysp. z o.o.	$175,174.05	viloway.com
DR Herbichsp. z o.o.	$170,344.07	drherbich.eu
Rohto-Mentholatum Europesp. z o.o.	$129,196.95	rohto.pl
Pexon Polandsp. z o.o.	$122,615.96	pexon.pl
Agro-Sorbsp. z o.o.	$98,845.83	agro-sorb.com
Biochefa Pharmaceutical Research and Production Plantsp. z o.o.	$97,517.22	biochefa.pl
Bioresearch PharmaS.A.	$76,294.71	bioresearchpharma.com
Amorphis Pharma Developmentsp. z o.o.	$35,766.66	amorphispharma.com